Asia-Pacific Cardiology Market: Market Size, Market Share and Forecast 2019-2025

Posted by shibaomrglobal on January 22nd, 2020

Asia-Pacific Cardiology Market is projected to grow significantly at a CAGR of 7.0% during the forecast period. The market is mainly driven owing to the large population with CVD, CHD, Stroke and other heart diseases. The other factors contributing to the market include rising healthcare spending, improving infrastructure and rising standards of living.

China, India, Japan, Australia, Korea, and Taiwan are the key economies growing at a significant rate due to the increasing demand for cardiology surgeries and devices. Along with that the rising adoption of innovative cardiology surgeries, robotic automation, and growing medical tourism in the region further provide ample opportunity for the growing market in the region.

To learn more about this report request a free sample copy @ https://www.omr.com/request-sample/asia-pacific-cardiology-market

The market is segmented on the basis of device type, drug type, mechanism, and surgeries type. Based on device type, the market is segregated angioplasty, cardiovascular stents, cardiovascular catheters, cardiac rhythm management, cardiovascular assistive devices.

Angioplasty and vascular stenting are widely adopted procedures in the cardiology market and have a considerable market share. Based on the drug type, the market is segmented into antithrombotic drugs, antidyslipidemic drugs, antihypertensive drugs, and anti-stroke drugs. On the basis of surgeries type, the market is classified into coronary artery bypass grafting, transmyocardial laser revascularization, heart valve repair, arrhythmia treatment, aneurysm repair, and heart transplant. 

Asia-Pacific Cardiology Market-Segmentation

By Device Type 

• Angioplasty 
• Cardiovascular stents
• Cardiovascular catheters
• Cardiac rhythm management
• Cardiovascular assistive devices

By Mechanism

• Antithrombotic drugs
• Antidyslipidemic drugs
• Antihypertensive drugs
• Anti-stroke drugs

By Surgeries Type

• Beta blockers
• Beta agonists
• Alpha blockers
• Alpha agonists
• Sodium channel blockers
• Calcium channel blockers
• Vasodilators
• Renin inhibitors
• Angiotensin receptor blockers
• Diuretics
• Thrombolytics

By Drug Type

• Coronary artery bypass grafting
• Transmyocardial laser revascularization
• Heart valve repair
• Arrhythmia treatment
• Aneurysm repair
• Heart transplant

Asia-Pacific Cardiology Market Regional

• China 
• India
• Japan 
• Rest of Asia-Pacific 

Company Profiles

• Abbott Laboratories 
• Boston Scientific Corp.
• Daiichi Sankyo Co. Ltd.
• F. Hoffmann-La Roche Ltd.
• General Electric Co.
• Johnson and Johnson Services Inc.
• Medtronic PLC
• Otsuka Pharmaceutical Co., Ltd.

About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Reports

Contact Person: Mr. Anurag Tiwari

Email: info@orionmarketreports.com    

Contact no: +1 646-755-7667, +91 780-304-0404